MX363993B - Composiciones farmaceuticas con actividad hidratante y lubricante. - Google Patents

Composiciones farmaceuticas con actividad hidratante y lubricante.

Info

Publication number
MX363993B
MX363993B MX2016006727A MX2016006727A MX363993B MX 363993 B MX363993 B MX 363993B MX 2016006727 A MX2016006727 A MX 2016006727A MX 2016006727 A MX2016006727 A MX 2016006727A MX 363993 B MX363993 B MX 363993B
Authority
MX
Mexico
Prior art keywords
pharmaceutical compositions
hydrating
lubricating activity
mucosa
compositions
Prior art date
Application number
MX2016006727A
Other languages
English (en)
Other versions
MX2016006727A (es
Inventor
Pilotto Laura
Gennari Giovanni
Maria Zanellato Anna
Original Assignee
Fidia Farm Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farm Spa filed Critical Fidia Farm Spa
Publication of MX2016006727A publication Critical patent/MX2016006727A/es
Publication of MX363993B publication Critical patent/MX363993B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención describe composiciones farmacéuticas que comprenden derivados de éster de ácido hialurónico para su uso como un tratamiento tópico en trastornos de la mucosa vaginal, caracterizados por la pérdida de elasticidad e hidratación, tal como una resequedad vaginal y/o vaginal atrófica; dichas composiciones también se pueden usar de manera exitosa para lubricar la mucosa genital.
MX2016006727A 2013-11-26 2014-11-17 Composiciones farmaceuticas con actividad hidratante y lubricante. MX363993B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT001971A ITMI20131971A1 (it) 2013-11-26 2013-11-26 Composizioni farmaceutiche ad attività idratante e lubrificante
PCT/EP2014/074736 WO2015078713A1 (en) 2013-11-26 2014-11-17 Pharmaceutical compositions with hydrating and lubricating activity

Publications (2)

Publication Number Publication Date
MX2016006727A MX2016006727A (es) 2016-08-11
MX363993B true MX363993B (es) 2019-04-10

Family

ID=49841735

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006727A MX363993B (es) 2013-11-26 2014-11-17 Composiciones farmaceuticas con actividad hidratante y lubricante.

Country Status (12)

Country Link
US (2) US20170020913A1 (es)
EP (1) EP3074023B1 (es)
KR (1) KR102353716B1 (es)
CA (1) CA2931370C (es)
EA (1) EA031959B1 (es)
ES (1) ES2658047T3 (es)
HR (1) HRP20180441T1 (es)
IL (1) IL245811B (es)
IT (1) ITMI20131971A1 (es)
MX (1) MX363993B (es)
SI (1) SI3074023T1 (es)
WO (1) WO2015078713A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITUB20160508A1 (it) * 2016-01-22 2017-07-22 Bios S R L Unipersonale Dispositivo a radiofrequenza per la lassità e il rimodellamento vaginale
CN111194218B (zh) * 2017-09-19 2024-02-20 香港科技大学 生物可相容材料以及用于制备和使用所述生物可相容材料的方法
WO2019226548A1 (en) * 2018-05-22 2019-11-28 Weinberg Assa Methods for prevention and treatment of urogenital atrophy of menopause by contact vasodilators
WO2020123312A1 (en) 2018-12-09 2020-06-18 Weinberg Assa Method to prevent and treat macular degeneration by vasodilators
IT201900019762A1 (it) 2019-10-24 2021-04-24 Fidia Farm Spa Composizione farmaceutica per uso nel trattamento della cistite di varia eziologia
EP4101437A4 (en) * 2020-02-12 2023-05-10 Shenzhen Eulikan Biotechnology Co., Ltd. BACTERIOSTATIC COMPOSITION, METHOD FOR PREPARATION AND USE
IT202000004582A1 (it) * 2020-03-06 2021-09-06 Alfasigma Spa Composizione farmaceutica utile per il trattamento e la prevenzione dell’atrofia e della secchezza vaginale.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO169637C (no) 1983-10-11 1992-07-22 Fidia Spa Fremgangsmaate for fremstilling av terapeutisk aktive hyaluronsyre-fraksjoner
US4851521A (en) 1985-07-08 1989-07-25 Fidia, S.P.A. Esters of hyaluronic acid
JPH0649257B2 (ja) * 1985-08-29 1994-06-29 豊田工機株式会社 手動ハンドルを備えた工作機械
IT1254704B (it) 1991-12-18 1995-10-09 Mini Ricerca Scient Tecnolog Tessuto non tessuto essenzialmente costituito da derivati dell'acido ialuronico
IT1259090B (it) * 1992-04-17 1996-03-11 Fidia Spa Biomaterialli per protesi d'osso
US6824793B1 (en) * 1998-06-01 2004-11-30 Chiron Corporation Use of hyaluronic acid polymers for mucosal delivery of vaccine antigens and adjuvants
IT1317359B1 (it) * 2000-08-31 2003-06-16 Fidia Advanced Biopolymers Srl Polisaccaridi percarbossilati, quali l'acido ialuronico, processo perla loro preparazione e loro impiego in campo farmaceutico e
US7238677B2 (en) * 2003-03-28 2007-07-03 Kimberly-Clark Worldwide, Inc. Prevention of urogenital infections
US20050095219A1 (en) * 2003-10-29 2005-05-05 Shu-Ping Yang Compositions for promoting vaginal cell proliferation and maturation
US20050181057A1 (en) * 2004-02-13 2005-08-18 Rosenberg Paul K. Vaginal lubricant
WO2006089561A1 (en) * 2005-02-23 2006-08-31 Abbas Abdelsalam Ghazi Pharmaceutical compositions containing organic acids useful for softening and ripening uterine cervix.
ITMI20071724A1 (it) * 2007-09-05 2009-03-06 Fidia Farmaceutici Formulazioni topiche antivirali in forma di gel bioadesivo
US8039024B2 (en) * 2008-01-23 2011-10-18 Apr Applied Pharma Research, S.A. Device and composition for the delivery of a preservative-free balsamic cream
IT1402385B1 (it) 2010-09-09 2013-09-04 Fidia Farmaceutici Processo per la produzione di acido ialuronico in escherichia coli o bacillus subtilis

Also Published As

Publication number Publication date
CA2931370C (en) 2022-07-05
EP3074023A1 (en) 2016-10-05
EP3074023B1 (en) 2017-12-27
MX2016006727A (es) 2016-08-11
US20200030365A1 (en) 2020-01-30
ITMI20131971A1 (it) 2015-05-27
SI3074023T1 (en) 2018-04-30
KR102353716B1 (ko) 2022-01-20
IL245811B (en) 2019-03-31
US20170020913A1 (en) 2017-01-26
HRP20180441T1 (hr) 2018-04-20
KR20160100296A (ko) 2016-08-23
WO2015078713A1 (en) 2015-06-04
CA2931370A1 (en) 2015-06-04
IL245811A0 (en) 2016-07-31
EA201690854A1 (ru) 2016-10-31
ES2658047T3 (es) 2018-03-08
EA031959B1 (ru) 2019-03-29
US11197886B2 (en) 2021-12-14

Similar Documents

Publication Publication Date Title
MX363993B (es) Composiciones farmaceuticas con actividad hidratante y lubricante.
PE20151727A1 (es) Acido 2-aza-biciclo[2.2.1]heptano-3-carboxilico (bencil-ciano-metil)-amidas sustituidas inhibidores de catepsina c
MX2015008627A (es) Derivados de acido boronico y usos terapeuticos de los mismos.
BR112015021888A2 (pt) inibidores de dna-ik
MX2016007067A (es) Microcapsulas lipidicas que comprenden de preferencia un retinoide y composicion que las contiene, su procedimiento de preparacion y su uso en dermatologia.
MX2020008031A (es) Composiciones y metodos para reducir el contenido de alcohol en sangre.
MX2015010125A (es) Derivados de piridazinona-amidas.
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
WO2014153009A3 (en) Thiosaccharide mucolytic agents
NZ719169A (en) Heteroaryl butanoic acid derivatives as lta4h inhibitors
MX2016004741A (es) Composicion farmaceutica que comprende un antagonista de trpa1 y un agente analgesico.
NZ720328A (en) Pyranochromenyl phenol derivative, and pharmaceutical composition for treating metabolic syndrome or inflammatory disease
CA2929436C (en) Compounds, pharmaceutical composition and methods for use in treating inflammatory diseases
CL2014002591A1 (es) Composicion topica semisolida que comprende pirfenidona, dialil oxido de disulfuro modificado (odd-m), un agente gelificante y otros excipientes o aditivos; proceso para fabricarla; metodo de tratamiento; y su uso para eliminar, reducir o prevenir el acne.
EA201592073A1 (ru) Фармацевтические композиции, содержащие коллаген и гиалуронат натрия
RS54131B1 (en) NEW PHARMACEUTICAL FORMULATION FOR FUNGAL INFECTION TREATMENT
MX367926B (es) Composicion farmaceutica para liberacion sostenida de lanreotida.
EA201492152A1 (ru) Налмефен для уменьшения потребления алкоголя у конкретных целевых популяций
MX2016001686A (es) Composicion para el tratamiento contra el envejecimiento de la piel.
MX370990B (es) Ésteres de ácidos oligo-hidroxicarboxílicos y uso de los mismos.
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
MX368640B (es) Composición farmacéutica para tratar inflamación y dolor.
EA201492238A1 (ru) Композиция мизопростола
EA201492088A1 (ru) Комбинированное терапевтическое средство для лечения ринита
TN2014000484A1 (en) Dronedarone for use in leishmaniasis, formulations and associations for use in leishmaniasis.

Legal Events

Date Code Title Description
FG Grant or registration